Last 7 days
-4.4%
Last 30 days
-6.4%
Last 90 days
-13.6%
Trailing 12 Months
-3.5%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
HCA | 73.0B | 60.9B | -4.91% | 25.24% | 12.73 | 1.2 | 1.94% | -15.77% |
LH | 20.7B | 14.8B | -2.77% | -13.32% | 16.22 | 1.39 | -6.96% | -52.35% |
DGX | 15.0B | 9.6B | -8.90% | -4.59% | 18.89 | 1.56 | -10.08% | -57.84% |
MID-CAP | ||||||||
UHS | 9.9B | 13.6B | -10.37% | 3.84% | 14.64 | 0.74 | 5.04% | -26.87% |
DVA | 8.5B | 11.7B | 9.28% | -3.24% | 16.63 | 0.73 | 0.42% | -43.11% |
CHE | 8.1B | 2.2B | -3.35% | 8.33% | 33.85 | 3.75 | 1.03% | -10.38% |
THC | 7.2B | 19.4B | -1.91% | 7.28% | 7.07 | 0.37 | 0.01% | -33.70% |
ACHC | 6.3B | 2.7B | -6.40% | -3.55% | 22.67 | 2.34 | 13.37% | 15.12% |
AMN | 3.9B | 4.8B | 11.84% | 2.65% | 10.12 | 0.8 | 3.57% | -4.88% |
PGNY | 3.5B | 786.9M | 14.80% | 10.69% | 81.89 | 4.48 | 57.19% | -22.51% |
SMALL-CAP | ||||||||
HNGR | 732.6M | - | 0.48% | -14.75% | 19.64 | 0.62 | - | - |
VMD | 394.4M | 146.1M | -12.69% | 63.35% | 63.38 | 2.84 | 20.87% | -35.06% |
OTRK | 12.8M | 14.5M | 9.91% | -70.47% | -0.25 | 0.88 | -82.75% | -38.85% |
IMAC | 10.6M | 17.9M | 13.80% | -34.42% | -0.75 | 0.59 | 26.72% | -85.04% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Revenue | 3.4% | 2,698 | 2,610 | 2,529 | 2,449 | 2,380 |
EBITDA | -2.3% | 422 | 432 | 421 | 373 | - |
EBITDA Margin | -5.4% | 0.16* | 0.17* | 0.14* | 0.16* | - |
Earnings Before Taxes | 1.7% | 380 | 374 | 382 | 370 | 326 |
EBT Margin | -5.2% | 0.14* | 0.15* | 0.13* | 0.14* | - |
Interest Expenses | -6.0% | -73.97 | -69.76 | -65.93 | -63.63 | -63.75 |
Net Income | 1.9% | 278 | 273 | 282 | 277 | 242 |
Net Income Margin | -6.3% | 0.10* | 0.11* | 0.09* | 0.10* | - |
Free Cahsflow | 24.3% | 84.00 | 68.00 | 170 | 139 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Assets | 1.1% | 5,044 | 4,988 | 4,943 | 4,883 | 4,835 |
Current Assets | 6.3% | 538 | 506 | 522 | 518 | 530 |
Cash Equivalents | -34.6% | 64.00 | 98.00 | 93.00 | 128 | 140 |
Inventory | -0.2% | 5.00 | 5.00 | 5.00 | - | - |
Net PPE | 2.4% | 1,998 | 1,952 | 1,909 | 1,857 | 1,796 |
Goodwill | 0% | 2,223 | 2,223 | 2,208 | 2,205 | 2,201 |
Liabilities | 1.3% | 2,114 | 2,087 | 2,111 | 2,144 | 2,190 |
Current Liabilities | -2.6% | 378 | 388 | 401 | 442 | 411 |
Long Term Debt | -0.3% | 1,401 | 1,405 | 1,485 | - | - |
LT Debt, Current | 0% | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 |
LT Debt, Non Current | 2.6% | 1,400 | 1,365 | 1,379 | 1,384 | 1,464 |
Shareholder's Equity | 1.0% | 2,840 | 2,813 | 2,744 | 2,663 | 2,575 |
Retained Earnings | 43.0% | 219 | 153 | 92.00 | 21.00 | -58.91 |
Additional Paid-In Capital | -1.5% | 2,619 | 2,658 | 2,651 | 2,641 | 2,633 |
Shares Outstanding | 1.2% | 91.00 | 90.00 | 90.00 | 90.00 | 89.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | -8.5% | 348 | 381 | 365 | 434 | 375 |
Share Based Compensation | -0.9% | 29.00 | 30.00 | 34.00 | 36.00 | 38.00 |
Cashflow From Investing | -5.6% | -323 | -305 | -443 | -440 | -404 |
Cashflow From Financing | 8.3% | -101 | -110 | -23.95 | -51.12 | -9.58 |
76.2%
44.6%
42.7%
Y-axis is the maximum loss one would have experienced if Acadia Healthcare Company was unfortunately bought at previous high price.
7.6%
2.6%
10.8%
34.3%
FIve years rolling returns for Acadia Healthcare Company.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-05-23 | Front Row Advisors LLC | unchanged | - | - | 6,000 | -% |
2023-05-23 | Brookfield Corp /ON/ | new | - | 348,679 | 348,679 | -% |
2023-05-22 | PUTNAM INVESTMENTS LLC | reduced | -76.44 | -3,434,750 | 895,611 | -% |
2023-05-22 | FDx Advisors, Inc. | unchanged | - | - | 639,000 | 0.03% |
2023-05-22 | AMERIPRISE FINANCIAL INC | reduced | -2.45 | -1,945,480 | 11,586,500 | -% |
2023-05-18 | JPMORGAN CHASE & CO | reduced | -7.97 | -57,544,800 | 241,773,000 | 0.03% |
2023-05-18 | NEW YORK STATE COMMON RETIREMENT FUND | reduced | -34.56 | -13,823,000 | 18,655,000 | 0.03% |
2023-05-17 | VIRGINIA RETIREMENT SYSTEMS ET AL | added | 21.05 | 367,146 | 1,704,020 | 0.02% |
2023-05-17 | Thrivent Financial for Lutherans | added | 10.18 | -329,000 | 9,666,000 | 0.02% |
2023-05-17 | Advisory Services Network, LLC | reduced | -99.6 | -248,727 | 867 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | t. rowe price investment management, inc. | 8.9% | 8,079,336 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.85% | 8,962,462 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 5.25% | 4,776,790 | SC 13G/A | |
Jan 25, 2023 | blackrock inc. | 9.0% | 8,208,758 | SC 13G | |
Feb 14, 2022 | price t rowe associates inc /md/ | 11.8% | 10,688,959 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 9.30% | 8,360,117 | SC 13G/A | |
Feb 08, 2022 | dimensional fund advisors lp | 6.0% | 5,375,423 | SC 13G/A | |
Feb 04, 2022 | wellington management group llp | 6.30% | 5,667,534 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 8.4% | 7,588,129 | SC 13G/A | |
Feb 16, 2021 | price t rowe associates inc /md/ | 11.6% | 10,332,194 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
May 19, 2023 | 4 | Insider Trading | |
May 19, 2023 | 8-K | Current Report | |
May 19, 2023 | 4 | Insider Trading | |
May 19, 2023 | 4 | Insider Trading | |
May 19, 2023 | 4 | Insider Trading | |
May 19, 2023 | 4 | Insider Trading | |
May 19, 2023 | 4 | Insider Trading | |
May 19, 2023 | 4 | Insider Trading | |
May 19, 2023 | 4 | Insider Trading | |
May 19, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-05-18 | Gregg Vicky B | acquired | - | - | 2,229 | - |
2023-05-18 | WAUD REEVE B | acquired | 241,970 | 43.209 | 5,600 | - |
2023-05-18 | Bissell E. Perot | acquired | - | - | 2,229 | - |
2023-05-18 | KELLY RALPH DAVID | acquired | 96,974 | 27.0879 | 3,580 | - |
2023-05-18 | Bernhard Jason | acquired | - | - | 2,229 | - |
2023-05-18 | OSTEEN DEBRA K | acquired | - | - | 2,229 | - |
2023-05-18 | Fucci Michael | acquired | - | - | 2,229 | - |
2023-05-18 | GRIECO WILLIAM | acquired | - | - | 2,229 | - |
2023-05-18 | Miquelon Wade D | acquired | - | - | 2,229 | - |
2023-05-09 | Hollinsworth John S. | acquired | - | - | 5,340 | evp of operations |
Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||
Revenue | $ 704,267 | $ 616,653 |
Salaries, wages and benefits (including equity-based compensation expense of $7,629 and $7,925, respectively) | 391,177 | 335,762 |
Professional fees | 41,125 | 36,911 |
Supplies | 26,021 | 23,699 |
Rents and leases | 11,424 | 11,249 |
Other operating expenses | 90,838 | 81,425 |
Depreciation and amortization | 31,569 | 28,926 |
Interest expense, net | 19,999 | 15,787 |
Transaction-related expenses | 6,471 | 3,582 |
Total expenses | 618,624 | 537,341 |
Income before income taxes | 85,643 | 79,312 |
Provision for income taxes | 19,085 | 17,402 |
Net income | 66,558 | 61,910 |
Net income attributable to noncontrolling interests | (543) | (1,073) |
Net income attributable to Acadia Healthcare Company, Inc. | $ 66,015 | $ 60,837 |
Earnings per share attributable to Acadia Healthcare Company, Inc. stockholders: | ||
Basic | $ 0.73 | $ 0.68 |
Diluted | $ 0.72 | $ 0.67 |
Weighted-average shares outstanding: | ||
Basic | 90,101 | 89,258 |
Diluted | 91,391 | 91,012 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 63,829 | $ 97,649 |
Accounts receivable, net | 346,407 | 322,439 |
Other current assets | 127,554 | 86,037 |
Total current assets | 537,790 | 506,125 |
Property and equipment, net | 1,998,037 | 1,952,045 |
Goodwill | 2,222,805 | 2,222,805 |
Intangible assets, net | 76,247 | 76,041 |
Deferred tax assets | 2,918 | 2,950 |
Operating lease right-of-use assets | 133,278 | 135,238 |
Other assets | 73,181 | 92,697 |
Total assets | 5,044,256 | 4,987,901 |
Current liabilities: | ||
Current portion of long-term debt | 21,250 | 21,250 |
Accounts payable | 125,729 | 104,723 |
Accrued salaries and benefits | 94,912 | 125,298 |
Current portion of operating lease liabilities | 26,415 | 26,463 |
Other accrued liabilities | 109,823 | 110,592 |
Total current liabilities | 378,129 | 388,326 |
Long-term debt | 1,399,778 | 1,364,541 |
Deferred tax liabilities | 92,767 | 92,588 |
Operating lease liabilities | 114,592 | 116,429 |
Other liabilities | 128,933 | 125,033 |
Total liabilities | 2,114,199 | 2,086,917 |
Redeemable noncontrolling interests | 90,455 | 88,257 |
Equity: | ||
Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued | ||
Common stock, $0.01 par value; 180,000,000 shares authorized; 90,953,107 and 89,913,659 issued and outstanding at March 31, 2023 and December 31, 2022, respectively | 910 | 899 |
Additional paid-in capital | 2,619,289 | 2,658,440 |
Retained earnings | 219,403 | 153,388 |
Total equity | 2,839,602 | 2,812,727 |
Total liabilities and equity | $ 5,044,256 | $ 4,987,901 |